The 13th national liver cancer conference was held at Chongqing International Convention and Exhibition Center from 15 to 18 September 2011. The conference invited many famous academicians and experts in the hepatobiliary surgery field, which provided us with a good platform to maintain the relationship of top experts in this academic field. During the conference, our company sponsored the VIP welcome dinner and maintained the good relationship of VIP experts in the surgical oncology field, which laid a solid foundation for the development of Tyroserleutide Phase III clinical trial.